WP
BMY icon

Woodline Partners’s Bristol-Myers Squibb BMY Stock Holding History

Woodline Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3M Buy
1,167,476
+46,838
+4% +$2.69M 0.21% 123
2026
Q1 		$68M Buy
1,120,638
+51,521
+5% +$3M 0.26% 85
2025
Q4 		$57.7M Buy
1,069,117
+78,866
+8% +$3.79M 0.22% 108
2025
Q3 		$44.7M Buy
990,251
+13,891
+1% +$649K 0.21% 130
2025
Q2 		$45.2M Sell
976,360
-315,255
-24% -$15.5M 0.24% 116
2025
Q1 		$78.8M Sell
1,291,615
-270,007
-17% -$15.7M 0.51% 29
2024
Q4 		$88.3M Buy
1,561,622
+783,466
+101% +$43.8M 0.6% 24
2024
Q3 		$40.3M Buy
778,156
+14,984
+2% +$703K 0.34% 91
2024
Q2 		$31.7M Sell
763,172
-6,082
-0.8% -$272K 0.3% 101
2024
Q1 		$41.7M Buy
769,254
+156
+0% +$7.95K 0.38% 72
2023
Q4 		$39.5M Buy
769,098
+531,618
+224% +$27.9M 0.43% 66
2023
Q3 		$13.8M Buy
237,480
+37,280
+19% +$2.28M 0.16% 179
2023
Q2 		$12.8M Sell
200,200
-61,413
-23% -$4.12M 0.15% 177
2023
Q1 		$18.1M Buy
261,613
+2,943
+1% +$208K 0.25% 116
2022
Q4 		$18.6M Sell
258,670
-9,230
-3% -$696K 0.25% 120
2022
Q3 		$19M Sell
267,900
-582,280
-68% -$42.2M 0.27% 109
2022
Q2 		$65.5M Buy
850,180
+454,610
+115% +$34.6M 1.01% 9
2022
Q1 		$28.9M Hold
395,570
– – 0.47% 61
2021
Q4 		$24.7M Hold
395,570
– – 0.35% 68
2021
Q3 		$23.4M Hold
395,570
– – 0.38% 71
2021
Q2 		$26.4M Sell
395,570
-211,261
-35% -$13.8M 0.49% 51
2021
Q1 		$38.3M Buy
+606,831
New +$37.8M 0.85% 30
2020
Q4 		– Sell
-1,103,742
Closed -$66.5M – 230
2020
Q3 		$66.5M Buy
+1,103,742
New +$66.4M 2.18% 7
2020
Q1 		– Sell
-552,945
Closed -$35.5M – 143
2019
Q4 		$35.5M Buy
+552,945
New +$31.7M 1.45% 24

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners's BMY Position: Q2 2026 in Review

Woodline Partners increased its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, buying an estimated $2.69M and bringing the position to 1,167,476 shares worth $67.3M. The position accounts for 0.21% of the portfolio, ranked #123.

Woodline Partners first reported a position in BMY in Q4 2019 and has held it in 24 quarters since. The position peaked at $88.3M in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Woodline Partners held 1,167,476 shares of Bristol-Myers Squibb worth $67.3M as of Q2 2026.
  • Woodline Partners bought 46,838 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.69M.
  • Bristol-Myers Squibb made up 0.21% of Woodline Partners's portfolio in Q2 2026, its #123 holding.
  • Woodline Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 24 quarters since.
  • Woodline Partners's Bristol-Myers Squibb position peaked at $88.3M in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.